• About
  • Products
  • News
  • Investor
    • Corporate
    • Financial
    • Stock
  • Contact
PanGenomic Health Signs Non-Binding Letter of intent for an Exclusive Special Purpose Licence of the CyberPatient AI Medical Education Platform

PanGenomic Health Signs Non-Binding Letter of intent for an Exclusive Special Purpose Licence of the CyberPatient AI Medical Education Platform

by PanGenomic | May 30, 2023 | Business Update

Vancouver, British Columbia, Canada, May 30, 2023 – PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA) (AQSE: NARA), is pleased to announce that it has entered into a non-binding letter of intent dated May 26, 2023...
PanGenomic Health Announces Financial Results for the 2022 Fiscal Year

PanGenomic Health Announces Financial Results for the 2022 Fiscal Year

by PanGenomic | May 3, 2023 | Business Update

VANCOUVER, BC, May 2, 2023 /CNW/ – PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA) (AQSE: NARA), is pleased to announce that it has filed its audited annual financial statements for the fiscal year...
PanGenomic Health Subsidiary Signs Master Services Agreement with Psy Integrated and Announces Repricing of Outstanding Warrants

PanGenomic Health Subsidiary Signs Master Services Agreement with Psy Integrated and Announces Repricing of Outstanding Warrants

by PanGenomic | Apr 21, 2023 | Business Update

VANCOUVER, BC, April 21, 2023 /CNW/ – PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA) (AQSE: NARA), is pleased to announce that, further to the announcement made on January 26, 2023, its...
PanGenomic Health Admitted to Trading on the AQSE Growth Market in London, United Kingdom

PanGenomic Health Admitted to Trading on the AQSE Growth Market in London, United Kingdom

by PanGenomic | Apr 12, 2023 | Business Update

Vancouver, British Columbia, Canada, April 12, 2023 – PanGenomic Health Inc. (“PanGenomic” or the “Company”) (CSE: NARA) (AQSE:NARA), is pleased to announce that it has completed its admission to the Access segment of the Aquis Stock Exchange (“AQSE”) and...
PanGenomic Health Retains UK Investor Relations Advisory Firm

PanGenomic Health Retains UK Investor Relations Advisory Firm

by PanGenomic | Apr 6, 2023 | Business Update

VANCOUVER, BC, April 6, 2023 /CNW/ – PanGenomic Health Inc. (“PanGenomic” or the “Company”) (CSE: NARA) is pleased to announce that Yellow Jersey PR Limited (“Yellow Jersey”) has been retained to provide investor relations and...
« Older Entries
Next Entries »

Recent Posts

  • PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests
  • PanGenomic Health Intends to Close Shares for Debt Settlement
  • PanGenomic Health Announces Financial Results for Half Year Ended June 30, 2023
  • PanGenomic Health Subsidiary Launches Vitamin D Health Assessments and Announces Corporate Appointments
  • PanGenomic Health Provides Update for NARA Product and Conversational AI

Recent Comments

No comments to show.
  • Follow
  • Follow
  • Follow
  • Follow

GET IN TOUCH

info@pangenomic.com

ABOUT US

Privacy Policy

Our Story

NEWSLETTER

Contact Us

© 2023 PanGenomic Health Inc.
A public benefit company.

Manage Cookie Consent
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}